QWM
DGX icon

Quaker Wealth Management’s Quest Diagnostics DGX Stock Holding History

Quaker Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-351
Closed -$59.4K – 1084
2025
Q1 		$59.4K Buy
+351
New +$57.7K 0.02% 137

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Quaker Wealth Management's DGX Position: Q2 2026 in Review

Quaker Wealth Management reduced its Quest Diagnostics (DGX) stake by 0.56% in Q2 2026, selling an estimated $393 and leaving 353 shares worth $74.8K. The position accounts for 0.02% of the portfolio, ranked #137.

Quaker Wealth Management first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Quaker Wealth Management held 353 shares of Quest Diagnostics worth $74.8K as of Q2 2026.
  • Quaker Wealth Management sold 2 Quest Diagnostics shares in Q2 2026, an estimated $393.
  • Quest Diagnostics made up 0.02% of Quaker Wealth Management's portfolio in Q2 2026, its #137 holding.
  • Quaker Wealth Management first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.